0001354488-13-002276.txt : 20130429
0001354488-13-002276.hdr.sgml : 20130427
20130429132555
ACCESSION NUMBER: 0001354488-13-002276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20030523
FILED AS OF DATE: 20130429
DATE AS OF CHANGE: 20130429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VILLIGER WALTER
CENTRAL INDEX KEY: 0001113655
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-18170
FILM NUMBER: 13790475
MAIL ADDRESS:
STREET 1: HURDNERSTRASSE 10, POSTFACH 1474
STREET 2: HURDEN
CITY: SEITZERLAND
STATE: V8
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2003-05-23
0
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001113655
VILLIGER WALTER
PARADIESSTRASSE 25
CH 8645 JONA
V8
00000
SWITZERLAND
1
Common Shares
2005-12-31
4
P
0
2360474
0.12
A
2760474
D
Common Shares
2006-05-01
4
C
0
2000000
A
4760474
D
Common Shares
2006-05-01
4
C
0
5625000
A
10385474
D
Common Shares
2006-05-01
4
X
0
1000000
0.04
A
11385474
D
Common Shares
2006-05-01
4
X
0
5625000
0.04
A
17010474
D
Common Shares
2006-05-01
4
X
0
750000
0.04
A
17760474
D
Common Shares
2006-05-01
4
P
0
1062941
0.06
A
18823415
D
Common Shares
2007-02-13
4
J
0
416666
0
A
19240081
D
Common Share Warrants
0.08
2003-05-23
4
J
0
750000
0
A
2003-05-23
2008-05-23
Common Stock
750000
750000
D
Common Share Warrants
0.04
2006-05-01
4
X
0
750000
0
D
2003-05-23
2008-05-23
Common Stock
750000
0
D
Series F Preferred Shares
2006-05-01
4
C
0
5000
200.01
D
2001-12-31
Common Stock
2000000
0
D
Series F Preferred Warrants
0.04
2006-05-01
4
X
0
2500
200.01
D
2001-12-31
2006-10-31
Common Stock
1000000
0
D
Series G Preferred Shares
2006-05-01
4
C
0
18
25000
D
2004-01-13
Common Stock
5625000
0
D
Series G Preferred Warrants
0.04
2006-05-01
4
X
0
18
25000
D
2004-01-13
2013-10-31
Common Stock
5625000
0
D
Common Share Warrants
0.07
2010-11-29
4
J
0
1000000
0
A
2010-11-29
2015-11-29
Common Shares
1000000
1000000
D
Common Share Warrants
0.063
2011-08-10
4
J
0
1000000
0
A
2011-08-10
2016-08-30
Common Shares
1000000
1000000
D
Common Share Warrants
0.08
2012-05-30
4
J
0
1000000
0
A
2012-05-30
2017-05-30
Common Shares
1000000
1000000
D
On May 23, 2003, the reporting person acquired 750,000 common share purchase warrants from the issuer in connection with the issuance of a 12-month promissory note evidencing a loan from the reporting person to the Issuer.
Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on December 31, 2005 closing price of Issuer?s common shares.
In March 2006, the Board of Directors approved a plan to raise additional capital from the holders of its outstanding warrants and stock options at a reduced price of $0.04 per share, in order to a) prevent further dilution by the issuance of additional securities to outsiders, and (b) to restructure the capitalization of the Company. On May 1, 2006, the reporting person converted the Series F preferred stock and Series G preferred stock into common shares, and exercised the Series F, Series G and May 23, 2003 warrants for shares of the issuer?s common stock, at an adjusted warrant exercise price of $0.04, to acquire a total of 15,000,000 shares of the company?s common stock.
Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on May 1, 2006 closing price of Issuer?s common shares.
Shares of common stock issued to reporting person in connection with financing costs related to Secured Multi-Draw Term Loan Facility Agreement in the amount of $2,000,000, with a maturity date of January 11, 2010.
Series F private placement consisted of units of Series F preferred shares and Series F warrants at a combined price of $200.01 per unit.
Series G private placement consisted of units of Series G preferred shares and Series G warrants at a combined price of $25,000 per unit.
Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $4,750,000 and extending the maturity date to January 11, 2013.
Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $5,250,000.
Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $5,750,000 and extending the maturity date to January 11, 2016.
/s/ WALTER VILLIGER
2013-04-29